The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives
Open accessAbstract
Our development and usage of engineered nanomaterials has grown exponentially despite concerns about their unfavourable cardiorespiratory consequence, one that parallels ambient ultrafine particle exposure from vehicle emissions. Most research in the field has so far focused on airway inflammation in response to nanoparticle inhalation, however, little is known about nanoparticle-microbiome interaction in the human airway and the environment. Emerging evidence illustrates that the airway, even in its healthy state, is not sterile. The resident human airway microbiome is further altered in chronic inflammatory respiratory disease however little is known about the impact of nanoparticle inhalation on this airway microbiome. The composition of the airway microbiome, which is involved in the development and progression of respiratory disease is dynamic, adding further complexity to understanding microbiota-host interaction in the lung, particularly in the context of nanoparticle exposure. This article reviews the size-dependent properties of nanomaterials, their body deposition after inhalation and factors that influence their fate. We evaluate what is currently known about nanoparticle-microbiome interactions in the human airway and summarise the known clinical, immunological and toxicological consequences of this relationship. While associations between inhaled ambient ultrafine particles and host immune-inflammatory response are known, the airway and environmental microbiomes likely act as intermediaries and facilitate individual susceptibility to inhaled nanoparticles and toxicants. Characterising the precise interaction between the environment and airway microbiomes, inhaled nanoparticles and the host immune system is therefore critical and will provide insight into mechanisms promoting nanoparticle induced airway damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Pope, C. A., Burnett, R. T., Thurston, G. D., Thun, M. J., Calle, E. E., Krewski, D., & Godleski, J. J. (2004) · Circulation · doi:10.1161/01.cir.0000108927.80044.7f · Cited by 2,592
Exposure to Environmental Microorganisms and Childhood Asthma
Ege, M. J., Mayer, M., Normand, A.-C., Genuneit, J., Cookson, W. O. C. M., Braun-Fahrländer, C., Heederik, D., Piarroux, R., & von Mutius, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007302 · Cited by 1,529
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
Genes and enzymes involved in bacterial oxidation and reduction of inorganic arsenic
Silver, S., & Phung, L. T. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.2.599-608.2005 · Cited by 612
Nanotoxicology: An Interdisciplinary Challenge
Krug, H. F., & Wick, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201001037 · Cited by 556
Bacterial topography of the healthy human lower respiratory tract
Dickson, R. P., Erb-Downward, J. R., Freeman, C. M., McCloskey, L., Falkowski, N. R., Huffnagle, G. B., & Curtis, J. L. (2017) · mBio · doi:10.1128/mbio.02287-16 · Cited by 548
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
Sakagami, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.012 · Cited by 331
Cited by
Said, Z., Sundar, L. S., Tiwari, A. K., Ali, H. M., Sheikholeslami, M., Bellos, E., & Babar, H. (2022) · Physics Reports · doi:10.1016/j.physrep.2021.07.002 · Cited by 391
Advancements in nanomaterials for nanosensors: a comprehensive review
Darwish, M. A., Abd-Elaziem, W., Elsheikh, A., & Zayed, A. A. (2024) · Nanoscale Advances · doi:10.1039/d4na00214h · Cited by 334
Polylactic acid (PLA)-based multifunctional and biodegradable nanocomposites and their applications
Islam, M. S., Elahee, G. M. F., Fang, Y., Yu, X. (., Advincula, R. C., & Cao, C. (. (2025) · Composites Part B Engineering · doi:10.1016/j.compositesb.2025.112842 · Cited by 86
Metadata
- Authors
- Poh, T. Y., Ali, N. A. B. M., Mac Aogáin, M., Kathawala, M. H., Setyawati, M. I., Ng, K. W., & Chotirmall, S. H.
- Venue
- Particle and Fibre Toxicology
- Published
- 2018-11-20
- Volume
- 15
- Issue
- 1
- Pages
- 46-46
- ISSN
- 1743-8977 (ISSN-L)
- OpenAlex
- W2901178795
- Cited by
- 169
- References
- 12
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives. https://app.cochat.ai/papers/10.1186/s12989-018-0282-0
- The paper
- Poh, T. Y., Ali, N. A. B. M., Mac Aogáin, M., Kathawala, M. H., Setyawati, M. I., Ng, K. W., & Chotirmall, S. H. (2018). Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives. Particle and Fibre Toxicology. https://doi.org/10.1186/s12989-018-0282-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.